Vulnerability Description
Cross-site scripting in the Intel(R) EMA software before version 1.8.0 may allow a privileged user to potentially enable escalation of privilege via local access.
CVSS Score
3.8
LOW
CVSS:3.1/AV:L/AC:H/PR:H/UI:R/S:U/C:L/I:L/A:L
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Intel | Endpoint Management Assistant | < 1.8.0 |
Related Weaknesses (CWE)
References
- https://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00716.Vendor Advisory
- https://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00716.Vendor Advisory
FAQ
What is CVE-2022-30297?
CVE-2022-30297 is a vulnerability with a CVSS score of 3.8 (LOW). Cross-site scripting in the Intel(R) EMA software before version 1.8.0 may allow a privileged user to potentially enable escalation of privilege via local access.
How severe is CVE-2022-30297?
CVE-2022-30297 has been rated LOW with a CVSS base score of 3.8/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2022-30297?
Check the references section above for vendor advisories and patch information. Affected products include: Intel Endpoint Management Assistant.